By expenditures
| Name | Title | Type |
|---|---|---|
| Eric Mayse | Chief Financial Officer | Auditee |
| Jansen Otterness | Partner | Auditee |
| Jansen Otterness | Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 366634 | 2024 | 2025-09-18 | Forvis Mazars LLP | $2.80M |
| 319560 | 2023 | 2024-09-13 | Forvis Mazars LLP | $4.94M |
| 24016 | 2022 | 2023-09-10 | Forvis LLP | $4.35M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 319560 | 2023 | 2024-09-13 | 1073279 | 2023-003 | Significant Deficiency | - | L |
| 319560 | 2023 | 2024-09-13 | 1073278 | 2023-003 | Significant Deficiency | - | L |
| 319560 | 2023 | 2024-09-13 | 1073277 | 2023-003 | Significant Deficiency | - | L |
| 319560 | 2023 | 2024-09-13 | 1073276 | 2023-003 | Significant Deficiency | - | L |
| 319560 | 2023 | 2024-09-13 | 1073275 | 2023-003 | Significant Deficiency | - | L |
| 319560 | 2023 | 2024-09-13 | 1073274 | 2023-002 | Significant Deficiency | - | I |
| 319560 | 2023 | 2024-09-13 | 1073273 | 2023-002 | Significant Deficiency | - | I |
| 319560 | 2023 | 2024-09-13 | 1073272 | 2023-002 | Significant Deficiency | - | I |
| 319560 | 2023 | 2024-09-13 | 1073271 | 2023-002 | Significant Deficiency | - | I |
| 319560 | 2023 | 2024-09-13 | 1073270 | 2023-002 | Significant Deficiency | - | I |
| 319560 | 2023 | 2024-09-13 | 496837 | 2023-003 | Significant Deficiency | - | L |
| 319560 | 2023 | 2024-09-13 | 496836 | 2023-003 | Significant Deficiency | - | L |
| 319560 | 2023 | 2024-09-13 | 496835 | 2023-003 | Significant Deficiency | - | L |
| 319560 | 2023 | 2024-09-13 | 496834 | 2023-003 | Significant Deficiency | - | L |
| 319560 | 2023 | 2024-09-13 | 496833 | 2023-003 | Significant Deficiency | - | L |
| 319560 | 2023 | 2024-09-13 | 496832 | 2023-002 | Significant Deficiency | - | I |
| 319560 | 2023 | 2024-09-13 | 496831 | 2023-002 | Significant Deficiency | - | I |
| 319560 | 2023 | 2024-09-13 | 496830 | 2023-002 | Significant Deficiency | - | I |
| 319560 | 2023 | 2024-09-13 | 496829 | 2023-002 | Significant Deficiency | - | I |
| 319560 | 2023 | 2024-09-13 | 496828 | 2023-002 | Significant Deficiency | - | I |